27.94

0.60% -0.17

After Hours: 27.89 -0.05 -0.18%

Rigel Pharmaceuticals (RIGL)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Rigel Pharmaceuticals stock is traded at $27.94, with a volume of 383.57K. It is down -0.60% in the last 24 hours and down -18.35% over the past month. Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.

Previous Close:

$28.11

Open:

$28.02

24h Volume:

383.57K

Relative Volume:

0.59

Market Cap:

$501.17M

Revenue:

$116.88M

Net Income/Loss:

$-25.09M

P/E Ratio:

-199.57

EPS:

-0.14

Net Cash Flow:

$-20.74M

1W Performance:

-0.85%

1M Performance:

-18.35%

6M Performance:

+65.82%

1Y Performance:

+84.54%

1-Day Range:

$27.75

$28.99

1-Week Range:

$26.38

$28.99

52-Week Range:

$13.57

$43.72

Rigel Pharmaceuticals Stock (RIGL) Company Profile

Name

Rigel Pharmaceuticals

Sector

Healthcare (1134)

Industry

Biotechnology (636)

Phone

650-624-1100

Address

611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA

Employee

164

Twitter

@rigelpharma

Next Earnings Date

2024-11-07

Latest SEC Filings

RIGL's Discussions on Twitter

Compare RIGL with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
RIGL Rigel Pharmaceuticals	27.94	504.22M	116.88M	-25.09M	-20.74M	-0.14
VRTX Vertex Pharmaceuticals Inc	416.81	104.76B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	481.67	63.06B	2.46B	-319.09M	-52.09M	-2.4669
REGN Regeneron Pharmaceuticals Inc	578.05	60.32B	14.21B	4.46B	3.56B	39.69
ARGX Argen X Se Adr	843.66	51.55B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	165.76	34.49B	398.11M	-1.03B	-868.57M	-5.7032

Rigel Pharmaceuticals Stock (RIGL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-03-23	Resumed	Piper Sandler	Neutral
Jun-09-22	Downgrade	Citigroup	Buy → Neutral
Jun-08-22	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Jun-08-22	Downgrade	Piper Sandler	Overweight → Neutral
Mar-23-22	Initiated	B. Riley Securities	Neutral
Nov-09-20	Downgrade	JP Morgan	Overweight → Neutral
Nov-15-19	Resumed	Cantor Fitzgerald	Overweight
Sep-26-19	Resumed	JP Morgan	Overweight
Mar-01-19	Reiterated	Cantor Fitzgerald	Overweight
Aug-27-18	Initiated	Citigroup	Buy
May-02-18	Reiterated	Cantor Fitzgerald	Overweight
Dec-21-17	Resumed	Piper Jaffray	Overweight
Dec-15-17	Initiated	Cantor Fitzgerald	Overweight
Nov-06-17	Resumed	H.C. Wainwright	Buy
Mar-09-17	Reiterated	H.C. Wainwright	Buy
Aug-31-16	Reiterated	H.C. Wainwright	Buy
Aug-30-16	Reiterated	Piper Jaffray	Overweight
Jul-13-16	Initiated	H.C. Wainwright	Buy
Jun-13-16	Initiated	Piper Jaffray	Overweight
Apr-22-16	Upgrade	JP Morgan	Neutral → Overweight
Apr-08-13	Reiterated	Stifel	Buy
Nov-29-12	Initiated	UBS	Neutral
Nov-06-12	Reiterated	Oppenheimer	Outperform
Mar-26-12	Initiated	Canaccord Genuity	Hold
Dec-10-10	Downgrade	MP Advisors	Outperform → Market Perform

View All

Rigel Pharmaceuticals Stock (RIGL) Latest News

Oct 18, 2025

Why Rigel Pharmaceuticals Inc. stock could see breakout soonVolume Spike & Safe Capital Growth Tips - newser.com

Oct 18, 2025

Momentum divergence signals in Rigel Pharmaceuticals Inc. chartJuly 2025 Final Week & Daily Profit Focused Stock Screening - newser.com

Oct 18, 2025

Is Rigel Pharmaceuticals Inc. stock a contrarian buyTrade Exit Summary & Low Risk High Win Rate Picks - newser.com

Oct 18, 2025

Will Rigel Pharmaceuticals Inc. stock benefit from green energy trendsJuly 2025 Gainers & Safe Entry Momentum Stock Tips - Trung tâm Dự báo KTTV quốc gia

Oct 18, 2025

Will Rigel Pharmaceuticals Inc. (RI2) stock profit from fiscal stimulusWeekly Earnings Recap & Stock Timing and Entry Methods - Trung tâm Dự báo KTTV quốc gia

Oct 18, 2025

Oct 17, 2025

Is this a good reentry point in Rigel Pharmaceuticals Inc.2025 Year in Review & Risk Controlled Swing Trade Alerts - newser.com

Oct 17, 2025

Why Rigel Pharmaceuticals Inc. stock is a value investor pickJobs Report & Safe Capital Investment Plans - Trung tâm Dự báo KTTV quốc gia

Oct 17, 2025

Oct 16, 2025

Rigel Pharmaceuticals Inc. stock volume spike explainedLayoff News & Free Technical Confirmation Trade Alerts - newser.com

Oct 16, 2025

Oct 15, 2025

What the charts say about Rigel Pharmaceuticals Inc. todayTrend Reversal & Stepwise Swing Trade Plans - newser.com

Oct 15, 2025

Is Rigel Pharmaceuticals Inc. stock recession proofQuarterly Profit Summary & Weekly High Conviction Ideas - newser.com

Oct 15, 2025

Is Rigel Pharmaceuticals Inc. trending in predictive chart modelsMarket Risk Summary & Capital Efficient Trading Techniques - newser.com

Oct 15, 2025

Are Investors Undervaluing Rigel Pharmaceuticals (RIGL) Right Now? - sharewise.com

Oct 15, 2025

Oct 14, 2025

Using portfolio simulators with Rigel Pharmaceuticals Inc. includedWeekly Investment Summary & Expert Approved Trade Ideas - newser.com

Oct 14, 2025

After Plunging 28% in 4 Weeks, Here's Why the Trend Might Reverse for Rigel (RIGL) - Yahoo Finance

Oct 14, 2025

Can Rigel Pharmaceuticals Inc. (RI2) stock double in coming years2025 Retail Activity & High Accuracy Trade Signal Alerts - newser.com

Oct 14, 2025

Can Rigel Pharmaceuticals Inc. stock deliver strong Q4 earningsLong Setup & Daily Volume Surge Trade Alerts - newser.com

Oct 14, 2025

Volume spikes in Rigel Pharmaceuticals Inc. stock – what they meanTrade Ideas & Weekly High Momentum Picks - newser.com

Oct 14, 2025

Oct 12, 2025

How Rigel Pharmaceuticals’ R289 Trial Progress and FDA Designations Will Impact RIGL Investors - Yahoo Finance

Oct 12, 2025

Oct 11, 2025